Predictors of survival for patients with brain metastases: results of a randomized phase III trial

W.J. Curran, M. Mehta, P. Rodrigus, C. Terhaard, A. Rao, J. Suh, W. Roa, L. Souhami, A. Bezjak, M. Leibenhaut, R. Komaki, C. Schultz, R. Timmerman, T. Illidge, S. Phan, J. Smith, A. DeVault, R. Miller, M.F. Renschler Thomas Jefferson University, Philadelphia, PA, University of Wisconsin, Madison, WI, Verbeeten Institute, Tilburg, Netherlands, Academisch Hospital, Utrecht, Netherlands, Kaiser Permanente, Los Angeles, CA, Cleveland Clinic, Cleveland, OH, Cross Cancer Institute, Edmonton, AB, Canada, Montreal General Hospital, Montreal, QC, Canada, Princess Margaret Hospital, Toronto, ON, Canada, Radiological Association of Sacramento, Sacramento, CA, UTMD Anderson, Houston, TX, Medical College of Wisconsin, Milwaukee, WI, Indiana University, Indianapolis, IN, Wessex Cancer Center, Southampton, United Kingdom, Pharmacyclics, Sunnyvale, CA